Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

ETF Stats for September 2012 – Largest Decline In Listings Ever

The quantity of ETP listings at the end of September was 18 fewer for the month and 20 fewer for the quarter, the largest declines ever.  The one-month closure tally of 24 also established a new record.  The current ETP listing count now stands at 1,456 and consists of 1,252 ETFs and 204 ETNs.  As stated a month ago – the consolidation has begun.

It’s not just due to the fact that closures have jumped – declines in new product launches are also a factor.  The 61 new products coming to market during the past half year is the lowest 6-month count since October 2009.  Only six new ETPs (five ETFs and one ETN) arrived on the market in September, the second month in a row for such a low total.

There are no signs of improvement either.  October will set another new record for closures with 29 liquidations already announced.

Many ETF reports would lead you to believe Russell has already closed 25 ETFs this year, pushing the year-to-date closure count above 80.  However, the reality is no Russell ETFs have been closed or liquidated yet.  Back in August, Russell “announced plans” to close and liquidate all ETFs but one in its product line.  Those plans provided for the continued listing and trading of the affected ETFs through October 16.  The 25 Russell ETFs are still in existence today, so don’t count your de-listings before they close.  The year-to-date actual closure count now stands at 59.

The spike in closures and resulting product consolidation are not signs of industry weakness.  Quite the opposite, they are traits of a healthy industry.  Not every product will be a winner.  A thoughtful pruning process is both necessary and beneficial.

8 Sector ETFs for 2013

Increasing assets under management is evidence of health, and assets grew another 5% in September to about $1.3 trillion.  The number of funds with more than $10 billion in assets rose from 24 to 28.  ETPs exceeding the $1 billion threshold climbed from 166 to 173.

Trading activity finally picked up after months of declining results.  Total dollar volume climbed back above $1 trillion, even though September had 17% fewer trading days than August (19 versus 23). SPDR S&P 500 (NYSEARCA:SPY) fell short of being responsible for a third of all ETP trading for the first time in memory.  It managed to capture “only” a 33.2% share.

ETPs averaging more than $1 billion per day in trading added one member to their ranks and captured 53.4% of all ETP trading activity.  Products averaging more than $100 million per day surged from 53 to 73 while capturing 88.0% of trading activity.  The quantity with more than $10 million of daily trading also increased, jumping from 208 to 236 while grabbing 97.3% of trading dollars.  Unfortunately, that means the remaining 1,200+ products, about 84%, had to fight for the last 2.7% of trading scraps.  While the overall ETF industry is healthly, it’s clearly a case of the haves and the have-nots.

ETF Stats for September 2012 – Largest Decline In Listings Ever

Data sources:  Daily prices and volume of individual ETPs from Norgate Premium Data.  Fund counts and all other information compiled by Invest With An Edge.

New products launched in September (sorted by launch date):


  1. RBS US Large Cap Alternator Exchange Traded Note (NYSEARCA:ALTL) [New RBS ETN Alternates Between 3 Large Cap Weighting Schemes]
  2. iShares MSCI Frontier 100 Index Fund (NYSEARCA:FM) [An MSCI Frontier ETF Finally Arrives]
  3. AdvisorShares STAR Global Buy-Write (NYSEARCA:VEGA) [VEGA ETF Has Mystery Target]
  4. WisdomTree China Dividend Ex-Financials Fund (NASDAQ:CHXF) [WisdomTree China Dividend Ex-Financials ETF Is Nearly Ex-Health Care, Too]
  5. FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund (NYSEARCA:TLTD) [New FlexShares ETFs Tilt International Markets]
  6. FlexShares Morningstar Emerging Markets Factor Tilt Index Fund (TLTE)

Product closures/delistings in September (sorted by name):

  1. Direxion Daily Agribusiness Bull 3x (COWL) [Direxion Closing Nine Leveraged and Inverse ETFs]
  2. Direxion Shares Exchange Traded Fund Trust (NYSEARCA:COWS)
  3. Direxion Daily Basic Materials Bear 3x (MATS)
  4. Direxion Daily BRIC Bull 3x (BRIL)
  5. Direxion Daily BRIC Bear 3x (BRIS)
  6. Direxion Daily Healthcare Bear 3x (SICK)
  7. Direxion Daily India Bear 3x (INDZ)
  8. Direxion Daily Latin America Bear 3x (LHB)
  9. Direxion Daily Retail Bear 3x (RETS)
  10. ETRACS 1-Month S&P 500 VIX Futures ETN (VXAA) [UBS Closing a Dozen VIX ETRACS ETNs]
  11. ETRACS 2-Month S&P 500 VIX Futures ETN (VXBB)
  12. ETRACS 3-Month S&P 500 VIX Futures ETN (VXCC)
  13. ETRACS 4-Month S&P 500 VIX Futures ETN (VXDD)
  14. ETRACS 5-Month S&P 500 VIX Futures ETN (VXEE)
  15. ETRACS 6-Month S&P 500 VIX Futures ETN (VXFF)
  16. ETRACS Daily Short 1-Month S&P VIX Futures ETN (AAVX)
  17. ETRACS Daily Short 2-Month S&P VIX Futures ETN (BBVX)
  18. ETRACS Daily Short 3-Month S&P VIX Futures ETN (CCVX)
  19. ETRACS Daily Short 4-Month S&P VIX Futures ETN (DDVX)
  20. ETRACS Daily Short 5-Month S&P VIX Futures ETN (EEVX)
  21. ETRACS Daily Short 6-Month S&P VIX Futures ETN (FFVX)
  22. iPath Short Extended (-3x) Russell 1000 TR ETN (ROSA) [SFSA and ROSA Hit Early Termination Trigger]
  23. iPath Short Extended (-3x) Russell 2000 TR ETN (RTSA) [RTSA: Another Day, Another iPath Early Termination]
  24. iPath Short Extended (-3x) S&P 500 TR Index ETN (SFSA)

Product changes in September:

  1. Global X changed the name, ticker symbol, and underlying index of the Global X S&P/TSX Venture 30 Canada ETF (TSXV) to Global X Funds (NYSEARCA:JUNR) effective September 6.  Although Global X trumpeted JUNR as a “new” ETF launch (pdf), it was actually just a marketing ploy, as TSXV was already a junior miners ETF.
  2. ProShares Trust II (NYSEARCA:UVXY) underwent a 1-for-10 reverse split effective September 7, 2012.
  3. Rydex Russell Top 50 (NYSEARCA:XLG) was renamed Guggenheim Russell Top 50 Mega Cap ETF (XLG) effective September 10, 2012.
  4. ETRACS Monthly 2xLeveraged Next Generation Internet ETN (EIPL) underwent a 1-for-4 reverse split effective September 12, 2012.
  5. Schwab cut the expense ratio on all 15 of its ETFs effective September 21, with each becoming the lowest cost offerings within their respective categories.
  6. Market Vectors-Coal (NYSEARCA:KOL) and Market Vectors Gaming (NYSEARCA:BJK) changed from using third-party indexes to in-house indexes effective September 24, 2012.

Announced Product Changes for Coming Months:

  1. Vanguard will change the underlying indexes for 22 of its funds over the coming months.  Six international funds will move from MSCI to FTSE indexes while 16 domestic products will transition from MSCI to CRSP indexes.
  2. Eight ProShares ETFs (TBT, SDS, SDOW, SMN, UBR, RXD, SZK, and GLL) will undergo a 1-for-4 reverse split and SVXY a 2-for-1 forward split effective October 5, 2012.
  3. Russell is making a strategic exit from the indexed ETF business by closing all 25 of its indexed ETFs, while leaving open its one actively managed ETF.  The last day of trading will be October 16, 2012.
  4. Global X will close four of its struggling ETFs.  October 18 will be the last day of trading for Global X Aluminum ETF (ALUM), Global X Auto ETF (VROM), Global X NASDAQ 400 Mid Cap ETF (QQQM), and Global X NASDAQ 500 ETF (QQQV).
  5. Guggenheim BulletShares 2012 Corporate Bond (BSCC) will terminate on or about December 31 due to its planned maturity and liquidation.
  6. Guggenheim BulletShares 2012 High Yield Corporate Bond (BSJC) will terminate on or about December 31 due to its planned maturity and liquidation.

Previous monthly ETF statistics reports are available here.

This article was originally written by Ron Rowland, and posted on InvestWithAnEdge.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!